Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-Ethanol Amine (PEA) Derivatives

N-Palmitoyl-ethanolamine (PEA) is an anti-inflammatory component of egg yolk that is usually employed for the prevention of respiratory apparatus virus infection and then frequently used for its efficient anti-inflammatory and analgesic effects in experimental models of visceral, neuropathic, and inflammatory diseases. Nevertheless, data of its use in animal or human therapy are still scarce and further studies are needed. Herein, we report the biological evaluation of a small library of N-palmitoyl-ethanolamine analogues or derivatives, characterized by a protected acid function (either as palmitoyl amides or hexadecyl esters), useful to decrease their hydrolysis rate in vitro and prolong their biological activity. Two of these compounds—namely phenyl-carbamic acid hexadecyl ester (4) and 2-methyl-pentadecanoic acid (4-nitro-phenyl)-amide (5)—have shown good anti-inflammatory and antioxidant properties, without affecting the viability of J774A.1 macrophages. Finally, crystals suitable for X-ray analysis of compound 4 have been obtained, and its solved crystal structure is here reported. Our outcomes may be helpful for a rational drug design based on new PEA analogues/derivatives with improved biological properties.

[1]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.

[2]  L. Petrelli,et al.  N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. , 1996, European journal of pharmacology.

[3]  L. Petrocellis,et al.  An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. , 1998, European journal of pharmacology.

[4]  Maria Cristina Burla,et al.  SIR97: a new tool for crystal structure determination and refinement , 1999 .

[5]  L. Petrocellis,et al.  Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. , 1999, Current medicinal chemistry.

[6]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[7]  V. Di Marzo,et al.  The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? , 1999, Current medicinal chemistry.

[8]  C. Fowler,et al.  The palmitoylethanolamide family: a new class of anti-inflammatory agents? , 2002, Current medicinal chemistry.

[9]  D. Parolaro,et al.  Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat , 2002, British journal of pharmacology.

[10]  T. Bisogno,et al.  Anandamide receptors. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  D. Greenberg,et al.  Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility , 2003, The Journal of Neuroscience.

[12]  S. Zucker,et al.  Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats , 2004, Hepatology.

[13]  B. Cravatt,et al.  The endogenous cannabinoid system and its role in nociceptive behavior. , 2004, Journal of neurobiology.

[14]  D. Piomelli,et al.  The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide , 2005, Molecular Pharmacology.

[15]  G. Sbardella,et al.  Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS. , 2005, Bioorganic & medicinal chemistry letters.

[16]  R. Levi‐montalcini,et al.  A proposed autacoid mechanism controlling mastocyte behaviour , 2005, Agents and Actions.

[17]  W. Wahli,et al.  PPARs in diseases: control mechanisms of inflammation. , 2005, Current medicinal chemistry.

[18]  R. Capasso,et al.  Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies , 2005, Neuropharmacology.

[19]  Roberto Russo,et al.  The search for the palmitoylethanolamide receptor. , 2005, Life sciences.

[20]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[21]  T. Bisogno,et al.  Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. , 2006, Biochimica et biophysica acta.

[22]  M. Cascio,et al.  New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. , 2006, Bioorganic & medicinal chemistry letters.

[23]  T. Bisogno,et al.  Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats , 2007, Neuropharmacology.

[24]  V. Marzo,et al.  Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. , 2007, Veterinary journal.

[25]  D. Barrett,et al.  ‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors , 2008, British journal of pharmacology.

[26]  T. Bisogno,et al.  Novel sterically hindered cannabinoid CB1 receptor ligands. , 2008, Bioorganic & medicinal chemistry.

[27]  S. Rault,et al.  Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives , 2009, Journal of enzyme inhibition and medicinal chemistry.

[28]  C. Saturnino,et al.  Acetamide Derivatives with Antioxidant Activity and Potential Anti-Inflammatory Activity , 2010, Molecules.

[29]  T. Bisogno,et al.  Protective role of palmitoylethanolamide in contact allergic dermatitis , 2009, Allergy.

[30]  T. Bisogno,et al.  Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. , 2010, Bioorganic & medicinal chemistry letters.

[31]  A. Capasso,et al.  New Amides of Arachidonic-Acid as Potential Antiinflammatory Drugs: A Preliminary Study. , 2010 .

[32]  S. Petrosino,et al.  N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. , 2010, Biochimie.

[33]  Fujio Izumi,et al.  VESTA 3 for three-dimensional visualization of crystal, volumetric and morphology data , 2011 .

[34]  J. Chao,et al.  Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit liver inflammation and fibrosis in rats. , 2011, The American journal of Chinese medicine.

[35]  D. Rossi,et al.  Chiral Flavanones from Amygdalus lycioides Spach: Structural Elucidation and Identification of TNFalpha Inhibitors by Bioactivity-guided Fractionation , 2012, Molecules.

[36]  A. Quaroni,et al.  Nivalenol and Deoxynivalenol Affect Rat Intestinal Epithelial Cells: A Concentration Related Study , 2012, PloS one.

[37]  E. Novellino,et al.  Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. , 2013, Bioorganic & medicinal chemistry letters.

[38]  M. Maggiolini,et al.  Synthesis, characterization and cytotoxic activity on breast cancer cells of new half-titanocene derivatives. , 2013, Bioorganic & medicinal chemistry letters.

[39]  Aurélien Lesnard,et al.  Synthesis and evaluation of cytotoxic activities of new guanidines derived from carbazoles. , 2014, Bioorganic & medicinal chemistry letters.

[40]  P. Campiglia,et al.  UHPLC profiling and effects on LPS-stimulated J774A.1 macrophages of flavonoids from bergamot (Citrus bergamia) juice, an underestimated waste product with high anti-inflammatory potential , 2014 .

[41]  R. Meli,et al.  Palmitoylethanolamide in CNS health and disease. , 2014, Pharmacological research.

[42]  M. Marazzi,et al.  TNF-α Blocker Effect of Naringenin-Loaded Sericin Microparticles that Are Potentially Useful in the Treatment of Psoriasis , 2014, International journal of molecular sciences.

[43]  P. Campiglia,et al.  Evaluation of anti-inflammatory activity and fast UHPLC-DAD-IT-TOF profiling of polyphenolic compounds extracted from green lettuce (Lactuca sativa L.; var. Maravilla de Verano). , 2015, Food chemistry.

[44]  P. Longo,et al.  Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes. , 2015, Bioorganic & medicinal chemistry.

[45]  G. Sheldrick.  Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.

[46]  P. Campiglia,et al.  Anti-inflammatory and antioxidant activity of polyphenolic extracts from Lactuca sativa (var. Maravilla de Verano) under different farming methods. , 2016, Journal of the science of food and agriculture.

[47]  D. Rossi,et al.  Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist. , 2016, Future medicinal chemistry.

[48]  N. Flamand,et al.  The CB2 receptor and its role as a regulator of inflammation , 2016, Cellular and Molecular Life Sciences.